WuXi Biologics Wins CDMO Leadership Awards Ninth Year
WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won “Biologics CDMO of the Year” (Large...
Tag : CDMO
Piramal Pharma Launches Tablet-in-Capsule Capabilities
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635), is pleased to...
Codis Debuts as Global CDMO for Spray Drying and ASD Solutions
New global CDMO combines commercial spray drying and particle engineering technologies under one brand. Codis officially launches as a new global CDMO specializing in commercial-scale...
ENCell’s EN001 Gets FDA Orphan Drug Designation for CMT
ENCell, a leading biopharmaceutical company for cell and gene therapy CDMO and novel drug development, announced today that its investigational drug EN001 has been granted...